Pharmabiz16m
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome: San Diego Thursday, January 16, 2025, 13:00 Hrs [IST] Acadia Pharmaceuticals In ...
Pharmabiz2h
Olfactive Biosolutions granted third dual GLP-1/GIP patent in US to repurpose food molecules for weight management and blood sugar regulation
Mountain View, California Thursday, January 16, 2025, 11:00 Hrs [IST] ...
Pharmabiz1h
Pasithea Therapeutics opens European clinical trial sites and completes initial dosing of cohort 4
Pasithea Therapeutics opens European clinical trial sites and completes initial dosing of cohort 4: Miami Thursday, January 16, 2025, 12:00 Hrs [IST] Pasithea Therapeutics Corp., ...
Pharmabiz20h
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy
Our Bureau, Bengaluru Wednesday, January 15, 2025, 16:45 Hrs [IST] ...
Pharmabiz21h
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients: Our Bureau, Mumbai ...
Pharmabiz4h
Health Canada approves MedMira’s Reveal G4 Rapid HIV-1/2 test for point-of-care use
Health Canada approves MedMira’s Reveal G4 Rapid HIV-1/2 test for point-of-care use: Halifax, Nova Scotia Thursday, January 16, 2025, 09:00 Hrs [IST] MedMira Inc. (MedMira) anno ...
Pharmabiz2d
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
Pharmabiz1d
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...
Pharmabiz1d
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...
Pharmabiz2d
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma: Paris Tuesday, January 14, 2025, 10:00 Hrs ...
Pharmabiz5h
With home health monitoring devices, India can improve public health: Tetsuya Yamada
With home health monitoring devices, India can improve public health: Tetsuya Yamada: Nandita Vijayasimha, Bengaluru Thursday, January 16, 2025, 08:00 Hrs [IST] India can establis ...
Pharmabiz5h
MSCDA urges DCGI to hear traders’ opinion before the committee on spurious drugs starts functioning
MSCDA urges DCGI to hear traders’ opinion before the committee on spurious drugs starts functioning: Peethaambaran Kunnathoor, Chennai Thursday, January 16, 2025, 08:00 Hrs [IST ...